We use own cookies and thirds to offer you better service More information Accept

Inke is specialized in respiratory APIs for inhalation

The Invent Farma Group, through its API subsidiary Inke, has specialized in the development and manufacture of active substances for use in respiratory inhalation therapies for the last two decades.

Given the stringent requirements for inhalators, our strategic commitment ensures a high level of our technical and regulatory standards making Inke a leading supplier in respiratory APIs.

Inke is a key supplier to major generic and branded companies worldwide.

Over 20 years experience in in-house micronization technology:

  • The isolation, final treatment and analysis of active substances for use in respiratory therapies are performed at special containment facilities
  • Process control of micronization grades achieved to ensure that each drug substance conforms to custom particle size distribution specification
  • Various patent applications
  • Certifications: EU-GMP, last FDA inspection April 2016, ISO 9001, ISO 14001, Certificates of Suitability (CEPs)
  • Customized Technical Support

Inke’s respiratory APIs product portfolio:

CoS = Products with Certificate of Suitability
P = Patent applications/granted patents owned by NuPharm Group
Products protected by valid patents are developed with no commercial purposes. These products are under development for uses related to the activities stated in the Art. 10.6 of the Directive 2001/83/EC amended by the Directive 2004/27/EC of the European Parliament and of the Council of 31 March 2004 and in the Art. 61.1(c) of the Spanish Patent Act, i.e. activities carried out to obtain a Marketing Authorization in Spain or out of Spain. None of the products are offered for sale or supplied to countries in which they could be in conflict with valid patents”

© NuPharm Group / INKE. All rights reserved.